-
Je něco špatně v tomto záznamu ?
Antibiofilm agent pterostilbene is able to enhance antibiotics action against Staphylococcus epidermidis
P. Kašparová, E. Vaňková, L. Brázdová, K. Lokočová, O. Maťátková, J. Masák
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- antibakteriální látky * farmakologie MeSH
- biofilmy MeSH
- faktory virulence MeSH
- mikrobiální testy citlivosti MeSH
- Staphylococcus epidermidis * MeSH
- stilbeny MeSH
- Publikační typ
- časopisecké články MeSH
Pterostilbene (PTE) is a naturally occurring compound originally isolated from Pterocarpus spp. It has been widely used in traditional Indian medicine and later discovered to have various beneficial pharmacological effects such as antioxidant properties, hypoglycaemic or antitumor, and antimicrobial activity. This work is focused on demonstrating PTE synergistic effect with erythromycin and tetracycline to reduce their needed effective concentration for suppression of Staphylococcus epidermidis planktonic cells growth and biofilm formation. The secondary aim is to find these combinations effect on the production of its virulence factors. PTE was found to be effective in inhibition of its planktonic cells with MIC80 values 25-37.5 mg l-1. Simultaneously, it decreased the metabolic activity of biofilm cells and was especially effective on a clinical isolate (MBIC80 = 35 mg l-1) in contrast to the conventional antibiotics. In combination, PTE helped the antibiotics to overcome the tolerance of S. epidermidis biofilm cells (5 mg l-1 of each antibiotic with 49 mg l-1 PTE caused more than 85% inhibition of metabolic activity). It permeabilized cytoplasmic membrane of S. epidermidis cells and altered their surface hydrophobicity. Therefore, PTE has a great potential to enhance antibiotics action in the treatment of infections caused by this pathogen.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019161
- 003
- CZ-PrNML
- 005
- 20250128100633.0
- 007
- ta
- 008
- 210728e20201123xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.micpath.2020.104632 $2 doi
- 035 __
- $a (PubMed)33242645
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kašparová, P $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic. Electronic address: kasparop@vscht.cz
- 245 10
- $a Antibiofilm agent pterostilbene is able to enhance antibiotics action against Staphylococcus epidermidis / $c P. Kašparová, E. Vaňková, L. Brázdová, K. Lokočová, O. Maťátková, J. Masák
- 520 9_
- $a Pterostilbene (PTE) is a naturally occurring compound originally isolated from Pterocarpus spp. It has been widely used in traditional Indian medicine and later discovered to have various beneficial pharmacological effects such as antioxidant properties, hypoglycaemic or antitumor, and antimicrobial activity. This work is focused on demonstrating PTE synergistic effect with erythromycin and tetracycline to reduce their needed effective concentration for suppression of Staphylococcus epidermidis planktonic cells growth and biofilm formation. The secondary aim is to find these combinations effect on the production of its virulence factors. PTE was found to be effective in inhibition of its planktonic cells with MIC80 values 25-37.5 mg l-1. Simultaneously, it decreased the metabolic activity of biofilm cells and was especially effective on a clinical isolate (MBIC80 = 35 mg l-1) in contrast to the conventional antibiotics. In combination, PTE helped the antibiotics to overcome the tolerance of S. epidermidis biofilm cells (5 mg l-1 of each antibiotic with 49 mg l-1 PTE caused more than 85% inhibition of metabolic activity). It permeabilized cytoplasmic membrane of S. epidermidis cells and altered their surface hydrophobicity. Therefore, PTE has a great potential to enhance antibiotics action in the treatment of infections caused by this pathogen.
- 650 12
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a biofilmy $7 D018441
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 12
- $a Staphylococcus epidermidis $7 D013212
- 650 _2
- $a stilbeny $7 D013267
- 650 _2
- $a faktory virulence $7 D037521
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vaňková, E $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic
- 700 1_
- $a Brázdová, Lada $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic $7 xx0326031
- 700 1_
- $a Lokočová, K $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic
- 700 1_
- $a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic $7 jo2017970315
- 700 1_
- $a Masák, J $u Department of Biotechnology, University of Chemistry and Technology in Prague, Technická 5, Prague 6 - Dejvice, 166 28, Czech Republic
- 773 0_
- $w MED00008641 $t Microbial pathogenesis $x 1096-1208 $g Roč. 152 (20201123), s. 104632
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33242645 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20250128100630 $b ABA008
- 999 __
- $a ok $b bmc $g 1690076 $s 1139607
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 152 $c - $d 104632 $e 20201123 $i 1096-1208 $m Microbial pathogenesis $n Microb Pathog $x MED00008641
- LZP __
- $a Pubmed-20210728